PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Product Catalogue

​Cryoprecipitate

Transfusion Medicine

​Alternate Product Names
  • ​Cryo
​Indications
  • ​Fibrinogen replacement in congenital hypofibrinogenemia or dysfibrinogenemia
  • Congenital hypofibrinogenemia
  • Acquired hypofibrinogenemia and bleeding:
    • Coagulopathic patients who have a  fibrinogen level less than 1.5 g/L
    • Obstetrical patients with uncontrolled bleeding who have a fibrinogen level less than 2.0 g/L
  • Factor XIII replacement in the setting of factor deficiency
​Resource Information
Size/Volume Available
  • 5 – 15 mL per unit
Availability
​RUH​SCH​SPH​Rural
​Yes​Yes​Yes​No
Pretransfusion Testing Requirements
  • ​ABO Group and Rh Type on current admission
    • Contact Transfusion Medicine prior to collection to confirm
Forms Required

​Saskatoon:

Ordering
  • Indicate number of units required
    • Dose guideline:  1 unit per 10 kg (average single adult dose is 8-10 units) 
​Notes
  • ​Rh compatibility not required
    • ABO compatibility preferred but not always available
  • Allow approximately 20 minutes for product to be thawed and/or pooled
    • Preparation of cryoprecipitate for infusion includes the addition of 10 mL 0.9% Sodium Chloride to facilitate product pooling
    • Approximate product equivalency for replacement of 1 gram of fibrinogen:
Product Component​Size​Volume
​Fibrinogen concentrate (RiaSTAP®)​1 vial ( 1 gram)​50 mL (reconstituted)
​Cryoprecipitate​3 units​30 mL
​Plasma (FP or FFP)​1 unit​350 mL
  • Choice of product for fibrinogen replacement and target fibrinogen level is a clinical decision based on patient condition
  • Available upon request during a Massive Transfusion Protocol, dependent on serum fibrinogen level or thromboelastograph (TEG) suggestive of hypofibrinogenemia 
​Administration

 

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-57 v4

Last Modified: Friday, January 26, 2018 |
Questions or feedback about this page?